Frequently Asked Questions
The market is segmented based on Global Kidney/Renal Function Test Market, By Product Type (Dipsticks, Reagents, Disposables), Test Type (Urine Tests, Blood Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others) – Industry Trends and Forecast to 2030.
.
The Global Kidney Renal Function Test Market size was valued at USD 874.70 USD Million in 2022.
The Global Kidney Renal Function Test Market is projected to grow at a CAGR of 6.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , AstraZeneca, Bristol Myers Squibb Company, F. Hoffmann, La Roche Ltd, Abbott, Danaher, bioMérieux, Siemens Healthcare Private Limited, BD, BioRad Laboratories , Sysmex Corporation, Nova Biomedical, Trinity Biotech, Alfa Scientific Designs , IDEXX, Beckman Coulter .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
